Cardiology fellow @nyulangone @BellevueHosp | IM @nyulangoneBK
New York, NY
Joined April 2021
- Tweets36
- Following125
- Followers109
- Likes549
Dena Hayes retweeted
Little late on this post, but figured I’d share with all 10 of my followers… 😅
Awesome work by our trainees at THT this year. Much more to come
@GolombeckMD @NehaParvMD @Caroline_Magro1 @DHayesMD @jliebs95 @MarziaLeacche @RandyGoldbergMD
@StephanieGolob @ArushiSinghMD
Dena Hayes retweeted
Calling all🫀AHFTC and purveyors of #critcarecards
Now that #ACC26 is over, come spend a weekend in NYC at the nation's #1 cardiac hospital to learn about what's new and exciting #CardiogenicShock #Transplant #LVAD #TAH and more! ONE month away. 🗣 Tell your friends!️
✍️Register now: nyulmc.org/heartfailurecme
Check out this lineup!
@ReyentovichHFMD @CarineHamo
@JasonKatzMD @SVRaoMD
#ISHLT2026 #Cardiology #CardioTwitter #CardioX #MedX #FITs #WIC #HeartFailure
Thank you @ACCinTouch for the opportunity to share our work on Cardiac Amyloidosis on Septal Myectomy Specimens of Patients with HCM
🫀1.6% (9/565) had amyloidosis on pathology - TTR, AL, AA
🫀 Findings suggest coexistence of HCM + amyloidosis in some pts
@danmassera #ACC2026
Enjoyed discussing national trends in heart transplantation in adults ≥70 at #THT2026
✅ >90% of programs performed HT in ≥70
📊 Marked variability across centers & UNOS regions
❌ No correlation with center volume
Future direction: identifying which ≥70 benefit most
Persistently elevated donor-derived cell-free DNA without rejection? 👀
@GolombeckMD highlights patients with chronically elevated cfDNA of unclear etiology, raising questions about management
Prospective studies needed to define why & how to manage
#THT2026 #ddcfDNA
During the Valvular Shock session 3/4 cases involved nonagenarians, reflecting shifting demographics of transcatheter valve population
Great discussion on complexity of care as patient age ⬆️ & transcatheter options expand, esp when advanced therapies aren’t an option #THT2026
Excited to be a Social Media Ambassador for #THT2026 — I’ll be sharing highlights throughout the meeting!
Your inside look at #THT2026 starts here! 🔥
Follow our Ambassadors for key updates, expert insights, and behind the scenes action from the conference’s biggest sessions. ow.ly/sUor50YmEQe
👉 @SophiaAirhartMD @michel_helou @RohangantiMD @igor_igorgosev @AHajduczok @DHayesMD @Ibrahim_Kamel9 @dor_lotan @DavidMajureMD @Nikhil15 @SomPSingh
#heartfailure #CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMD @javedbutler1 @preventfailure @akshaydesaimd @JerryEstepMD @FudimMarat @UlrichJordeMD @manreetkanwar @dranulala @MartyBLeon @LindenfeldJoann @SMarxLab @gtsayer @WilsonTangMD @NirUrielMD @jgranadacrf @triciarawh @TCTConference @HFSA @asaiojournal @ISHLT @JCardFail
Check out our review article on Strain Imaging in Heart Failure @drmishbloom @JStojanovskaMD
sciencedirect.com/science/ar…
1
3
148
Dena Hayes retweeted
Do all post PCI pts need the same obs period?
Fantastic study by Dr. Joey Lerner @nyulangone Cardiology fellow showing that individualized milestone-based observation reduces LOS!
Check out this fascinating case of cardiac sarcoidosis presenting as a biatrial mass at #ACC25 today & simultaneous publication in @JACCJournals 🫀🔬
@RandyGoldbergMD @DanyaalMoinMD @albertjungmd
jacc.org/doi/10.1016/j.jacca…
Dena Hayes retweeted
Vutrisiran, a TTR silencer, is now FDA-approved for transthyretin cardiac amyloidosis- along w/two FDA-approved stabilizers, tafamidis and acoramidis.
There is no trial evidence to guide single vs combo therapy.
What will be your go-to regimen for ATTR-CM? Explain in comments!
7%TTR stabilizer only
12%TTR silencer only
40%Stabilizer + silencer
41%Results, please!
165 votes • Final results Dena Hayes retweeted
Absolutely loved running into my @ACCinTouch #WIC mentee in between TAVRs @DHayesMD, now cardiology fellow🫀❤️ on her Cath Lab rotation @nyulangone @nyugrossman! Looking forward to taking care of valve patients together. #WomenInCardiology #ACCFIT #StructuralFellow @WomenAs1
Dena Hayes retweeted
1/ You are consulted overnight for a 66M found hypothermic and unresponsive in his home…
Time for #12LeadThursday 🫀⤵️
📺: youtu.be/LNX_otkniHo?si=pB7s…
🖥️: coreimpodcast.com/2024/07/11…
Dena Hayes retweeted
#GDMT use has increased over time
2/5 patients did not receive all recommended #HeartFailure medications at discharge
Reduced likelihood of receipt in:
🔸 Women
🔸 Minority patients
🔸 Urban hospitals
📎 bit.ly/4aS7o7X
#JACCHF @paheidenreich @UREssien @StanSwatMD
Dena Hayes retweeted
@DHayesMD presenting on transbrachial biopsy for heart transplant rejection surveillance
Takeaways:
1-safe
2-shorter procedure time
3-preferred by patients
@amitalamMD @ReyentovichHFMD @KadoshBernard @RandyGoldbergMD
Dena Hayes retweeted
#OriginalResearch: Among newly diagnosed HFrEF patients, optimal GDMT utilization within 12 months was low, with significant disparity between women compared with men #AHAJournals ahajournals.org/doi/10.1161/…
Dena Hayes retweeted
#JADEL
A marvelous report in @CASEfromASE from @saricmu et al demonstrating the TUPLE maneuver ("tilt up, turn left") to facilitate LAAO device placement.
Another must read in CASE:
doi.org/10.1016/j.case.2023.…
@CASEfromASE